Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.81 USD | -2.04% | -3.34% | +41.73% |
May. 13 | Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating | MT |
May. 10 | Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Instil Bio, Inc.
Upcoming events on Instil Bio, Inc.
Past events on Instil Bio, Inc.
2024-05-10 07:00 am | Q1 2024 Earnings Release |
2024-03-21 05:00 pm | Q4 2023 Earnings Release |
2023-06-13 | Annual General Meeting |
2023-05-11 07:02 am | Q1 2023 Earnings Release |
2023-03-31 07:00 am | Q4 2022 Earnings Release |
2022-09-29 10:30 am | Jefferies Cell and Genetic Medicine Summit |
2022-09-12 02:50 pm | Morgan Stanley Global Healthcare Conference |
2022-05-20 10:00 am | Annual General Meeting |
2022-03-07 07:00 am | FY 2021 Earnings Release |
2021-08-12 07:00 am | Interim 2021 Earnings Release |
2021-06-04 09:30 am | Jefferies Healthcare Conference |
2021-05-13 07:00 am | Q1 2021 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,14 | 0,00 0,03 - | 0,00 0,33 - | 0,00 0,00 - | 0,00 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -127 -125 -1.29% | -190 -191 0.52% | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -156 -145 -7.09% | -226 -218 -3.66% | -159 -164 3.24% | -75,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -157 -151 -3.99% | -225 -226 0.13% | -156 -162 3.49% | -77,0 |
Net income Million USD | Released Forecast Spread | -37,7 | -157 -150 -4.67% | -223 -224 0.44% | -156 -162 3.49% | -77,0 |
EPS USD | Released Forecast Spread | -56,6 | -29,6 -29,7 0.22% | -34,4 -34,3 -0.29% | -24,0 -24,9 3.42% | -11,4 |
Announcement Date | 26/02/21 | 07/03/22 | 31/03/23 | 21/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,33 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -54,3 -49,4 -9.81% | -58,7 -54,1 -8.63% | -56,6 -58,5 3.12% | -56,8 -55,3 -2.8% | -33,9 -21,2 -60.1% | -16,6 -23,0 27.95% | -20,4 -16,5 -24.21% | -13,0 -18,4 29.05% | -24,0 -14,5 -64.89% | -18,7 | -16,8 | -16,2 | -21,9 | -26,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -54,6 -49,6 -10.11% | -59,6 -55,2 -7.93% | -56,6 -57,7 1.88% | -54,4 -54,4 -0.16% | -57,1 -20,0 -185.43% | -18,7 -21,4 12.9% | -67,4 -14,3 -370.75% | -12,9 -18,6 30.37% | -24,3 -14,5 -67.25% | -19,0 | -17,2 | -16,5 | -22,2 | -27,2 |
Net income Million USD | Released Forecast Spread | -54,6 -49,6 -10.11% | -59,0 -55,2 -6.83% | -56,2 -57,7 2.53% | -53,8 -54,4 0.96% | -57,1 -22,6 -152.6% | -18,7 -21,4 12.9% | -67,4 -14,3 -370.75% | -12,9 -18,6 30.37% | -24,3 -14,5 -67.25% | -19,0 | -17,2 | -16,5 | -22,2 | -27,2 |
EPS USD | Released Forecast Spread | -8,40 -7,67 -9.57% | -9,20 -8,40 -9.52% | -8,60 -8,90 3.37% | -8,20 -8,20 0% | -8,80 -6,87 -28.16% | -2,80 -2,95 5.08% | -10,4 -2,00 -420% | -1,99 -2,85 30.05% | -3,74 -2,23 -67.71% | -2,92 | -2,63 | -2,35 | -2,96 | -3,62 |
Announcement Date | 16/05/22 | 12/08/22 | 14/11/22 | 31/03/23 | 11/05/23 | 14/08/23 | 13/11/23 | 21/03/24 | 10/05/24 | - | - | - | - | - |
2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Instil Bio, Inc.
2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TIL Stock
- Calendar Instil Bio, Inc.